Iannazzo, Sergio, SIHS Health Economics Consulting, Turin, Italy

• Vol 18, No 1 (2017) - Original research
  Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study
  Abstract  HTML  PDF